Por favor, use este identificador para citar o enlazar este ítem:
http://conacyt.repositorioinstitucional.mx/jspui/handle/1000/7652
Significant Broad Spectrum Antiviral activity of Bi121 Against Different Variants of SARS-CoV-2 | |
Bobban Subhadra Ragini Agrawal Virender Kumar Agnes Chenine Jeffy George Mattathil Amit Singh | |
Acceso Abierto | |
Atribución-NoComercial-SinDerivadas | |
https://doi.org/10.1101/2022.01.29.477140 | |
https://www.biorxiv.org/content/10.1101/2022.01.29.477140v1 | |
The SARS-CoV-2 pandemic infected 343 million people with over 5.59 million deaths. New mutated lineages of SARS-CoV-2 such as Omicron are evolving faster. Broad-spectrum viral inhibitors that block the initial stage of infection by reducing virus proliferation and disease severity is an unmet global medical need. We studied Bi121, a standardized polyphenolic-rich compound isolated from Pelargonium sideodes, against recombinant Vesicular Stomatitis Virus (rVSV)-pseudotyped SARS-CoV-2S (spike) that represent mutations in the spike protein of six different variants of SARS-CoV-2. Bi121 was effective in neutralizing all six rVSV-ΔG-SARS-CoV-2S variants expressing different mutations. The antiviral activity of Bi121 was then assessed against three variants of SARS-CoV-2 (USA WA1/2020, Hongkong/VM20001061/2020, B.1.167.2 (Delta)) using RT-qPCR and plaque assays in two different cell lines (Vero cells and HEK-ACE2). Bi121 showed significant activity toward all the three variants tested, suggesting a broad-spectrum activity. | |
medRxiv and bioRxiv | |
31-01-2022 | |
Preimpreso | |
https://www.biorxiv.org/ | |
Inglés | |
Epidemia COVID-19 | |
Público en general | |
VIRUS RESPIRATORIOS | |
Versión publicada | |
publishedVersion - Versión publicada | |
Aparece en las colecciones: | Artículos científicos |
Cargar archivos:
Fichero | Tamaño | Formato | |
---|---|---|---|
Significant Broad Spectrum Antiviral activity of Bi121 Against different Variants.pdf | 953.62 kB | Adobe PDF | Visualizar/Abrir |